- Home
- DRUG vs PCB Comparison
DRUG vs PCB Comparison
Compare DRUG & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PCB
- Stock Information
- Founded
- DRUG 2019
- PCB 2003
- Country
- DRUG United States
- PCB United States
- Employees
- DRUG N/A
- PCB N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PCB Major Banks
- Sector
- DRUG Health Care
- PCB Finance
- Exchange
- DRUG Nasdaq
- PCB Nasdaq
- Market Cap
- DRUG 253.2M
- PCB 265.5M
- IPO Year
- DRUG N/A
- PCB N/A
- Fundamental
- Price
- DRUG $36.06
- PCB $18.53
- Analyst Decision
- DRUG Strong Buy
- PCB Hold
- Analyst Count
- DRUG 4
- PCB 2
- Target Price
- DRUG $84.33
- PCB $22.00
- AVG Volume (30 Days)
- DRUG 50.7K
- PCB 21.3K
- Earning Date
- DRUG 02-14-2025
- PCB 04-24-2025
- Dividend Yield
- DRUG N/A
- PCB 4.30%
- EPS Growth
- DRUG N/A
- PCB N/A
- EPS
- DRUG N/A
- PCB 1.74
- Revenue
- DRUG N/A
- PCB $96,309,000.00
- Revenue This Year
- DRUG N/A
- PCB $16.13
- Revenue Next Year
- DRUG N/A
- PCB $10.77
- P/E Ratio
- DRUG N/A
- PCB $10.68
- Revenue Growth
- DRUG N/A
- PCB N/A
- 52 Week Low
- DRUG $0.93
- PCB $14.50
- 52 Week High
- DRUG $79.02
- PCB $22.20
- Technical
- Relative Strength Index (RSI)
- DRUG 49.87
- PCB 38.30
- Support Level
- DRUG $31.55
- PCB $18.16
- Resistance Level
- DRUG $36.25
- PCB $18.87
- Average True Range (ATR)
- DRUG 2.74
- PCB 0.43
- MACD
- DRUG 0.01
- PCB -0.08
- Stochastic Oscillator
- DRUG 66.15
- PCB 20.22
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals.